首页> 外国专利> Use of ginseng extracts, ginsenosides and ginsenoside derivatives in the manufacture of a medicament or health care product for treating a cytomegalovirus infection disorder

Use of ginseng extracts, ginsenosides and ginsenoside derivatives in the manufacture of a medicament or health care product for treating a cytomegalovirus infection disorder

机译:人参提取物,人参皂甙和人参皂甙衍生物在生产用于治疗巨细胞病毒感染性疾病的药物或保健产品中的用途

摘要

Disclosed is the use of ginseng extracts, ginsenosides and ginsenoside derivatives in the manufacture of a medicament or health care product for the treatment of human cytomegalovirus infection-related diseases. Related diseases include patients suffering from cardiovascular and cerebrovascular diseases, organ transplants, perinatal, tumors, burns, AIDS and other diseases infected by human cytomegalovirus during treatment. Experiments have shown that ginseng extracts, ginsenosides and ginsenoside derivatives are simple and effective for treating human cytomegalovirus infections, as they are significantly and quickly effective, less toxic, and less side effects in the treatment of human cytomegalovirus infection diseases. It is a safe, effective, stable medicament or health care product with a manufacturing process and demonstrates its suitability and ease of dissemination for industrial production. The present invention provides new sources of medicaments for treating human cytomegalovirus infections.
机译:公开了人参提取物,人参皂苷和人参皂苷衍生物在制备用于治疗与人类巨细胞病毒感染相关的疾病的药物或保健产品中的用途。相关疾病包括患有心血管和脑血管疾病,器官移植,围产期,肿瘤,烧伤,艾滋病和其他在治疗期间被人巨细胞病毒感染的疾病的患者。实验表明,人参提取物,人参皂苷和人参皂苷衍生物对于治疗人巨细胞病毒感染是简单有效的,因为它们在治疗人巨细胞病毒感染疾病中有效且迅速,毒性小且副作用小。它是一种安全,有效,稳定的药物或保健产品,具有制造过程,并证明了其适用性和易于在工业生产中传播。本发明提供了用于治疗人巨细胞病毒感染的药物的新来源。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号